References
- Brange J, Langkjoer, L. Insulin structure and stability. Pharm Biotechnol 1993;5:315–50
- Carino GP, Mathiowitz E. Oral insulin delivery. Adv Drug Deliv Rev 1999;35:249–57
- Arbit E. The physiological rationale for oral insulin administration. Diabetes Technol Ther 2004;6:510–17
- Arbit E, Kidron M. Oral insulin: the rationale for this approach and current developments. J Diabetes Technol 2009;3:562–7
- Woitiskia CB, Neufeld RJ, Veiga F, et al. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles. Eur J Pharm Sci 2010;41:556–63
- Heinemann LL, Klappoth W, Rave K, et al. Intraindividual variability in metabolic effect of inhaled insulin together with an absorption enhancer. Diabetes Care 2000;23:1343–7
- Vaz JA, Patnaik A. Diabetes mellitus: exploring the challenges in drug development process. Prospect Clin Res 2012;3:109–12
- Boss AH, Petrucci R, Lorber D. Coverage of prandial insulin requirements by means of an ultra-rapid-acting inhaled insulin. J Diabetes Sci Technol 2012;6:773–9
- Rave KL, Nosek L, de la Peña A, et al. Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro. Diabetes Care 2005;28:2400–5
- Delie F, Blanco-Prıeto MJ. Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules 2005;10:65–80
- Reshka MR, Sharma CP. Oral delivery of therapeutic protein/peptide for diabetes – future perspectives. Int J Pharm 2013;440:48--62
- Bowey K, Swift BE, Flynn LE, Neufeld RJ. Characterization of biologically active insulin-loaded alginate microparticles prepared by spray drying. Drug Dev Ind Pharm 2013;39:457–65
- Van der Lubben IM, Verhoef JC, Borchard G, Junginger HE. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci 2001;14:201–7
- Modi J, Joshi G, Sawant K. Chitosan based mucoadhesive nanoparticles of ketoconazole for bioavalibility enhancement: formulation, optimization, in vitro and ex-vivo evaluation. Drug Dev Ind Pharm 2013;39:540–7
- Wong TW, Nurulaini H. Sustained-release alginate chitosan pellets prepared by melt pelletization techniques. Drug Dev Ind Pharm 2012;38:1417–27
- Chen W, Fan D, Meng L, et al. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats. Drug Dev Ind Pharm 2012;38:104–10
- Sajomsang W, Gonil P, Saesoo S, Ovatlarnporn C. Antifungal property of quaternized chitosan and its derivatives. Int J Biol Macromol 2012;50:263–9
- Avadi MR, Jalali A, Sadeghi AM, et al. Diethyl methyl chitosan as an intestinal paracellular enhancer: ex vivo and in vivo studies. Int J Pharm 2005;293:83–9
- Yin L, Ding J, He C, et al. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 2009;30:5691–700
- Shu S, Zhang X, Wu Z, et al. Delivery of protein drugs using nanoparticles self-assembled from dextran sulfate and quaternized chitosan. J Control Release 2011;152:e170–2
- Opanasopit P, Sajomsang W, Ruktanonchai U, et al. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan as effective gene carriers: effect of degree of substitution. Carbohydr Polym 2009;75:143–9
- Rojanarata T, Petchsangsai M, Opanasopit P, et al. Methylated N-(4-N,N-dimethyl aminobenzyl) chitosan for novel effective gene carriers. Eur J Pharm Biopharm 2008;70:207–14
- Opanasopit P, Sajomsang W, Ruktanonchai U, et al. Methylated N-(4-pyridinylmethyl) chitosan as a novel effective safe gene carrier. Int J Pharm 2008;364:127–34
- Kowapradit J, Opanasopit P, Ngawhiranpat T, et al. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan, a novel chitosan derivative, enhances paracellular permeability across intestinal epithelial cells (Caco-2). AAPS PharmSciTech 2008;9:1143–52
- Mahjub R, Dorkoosh FA, Amini M, et al. Preparation, statistical optimization and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan. AAPS PharmSciTech 2011;12:1407–19
- Sandri G, Bonferoni MC, Rossi S, et al. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models. Eur J Pharm Biopharm 2007;65:68–77
- Bayat A, Larijani B, Ahmadian S, et al. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives. Nanomedicine 2008;4:115–20
- Mao S, Bakowsky U, Jintapattanakit A, Kissel T. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J Pharm Sci 2006;95:1035–48
- Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–33
- Mansour HM, Sohn M, Al-Ghananeem A, Deluca PP. Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects. Int J Mol Sci 2010;11:3298–322
- Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 1969;58:1253–7
- Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determinations – theoretical considerations and application to non-disintegrating dosage forms. J Pharm Sci 1967;56:1238–42
- Hixson JW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem 1931;23:923–31
- Niebergall PJ, Milosovich G, Goyan JE. Dissolution rate studies. II. Dissolution of particles under conditions of rapid agitation. J Pharm Sci 1963;52:236-41
- Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 1961;50:874–5
- Siepmanna J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2000;48:139–57
- Ritger PL, Peppas NA. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-sweliable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1987;5:23–36
- Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. Reversed chitosan–alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterization. Eur J Pharm Biopharm 2007;65:215–32
- Werle M, Takeuchi H, Bernkop-Schnürch A. Modified chitosans for oral drug delivery. J Pharm Sci 2009;98:1643–56
- Van Eerdenbrugh B, Vercruysse S, Martens JA, et al. Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions – a case study with itraconazole. Eur J Pharm Biopharm 2008;70:590–6
- Guan T, Miao Y, Xu L, et al. Injectable nimodipine-loaded nanoliposomes: preparation, lyophilization and characteristics. Int J Pharm 2011;410:180–7
- Chance RE, Kroeff EP, Hoffmann JA, et al. Chemical, physical, and biologic properties of biosynthetic human insulin. Diabetes Care 1981;4:147–54
- Emami J, Hamishehkar H, Najafabadi AR, et al. A novel approach to prepare insulin-loaded poly (lactic-co-glycolic acid) and the protein stability study. J Pharm Sci 2009;98:1712–31
- Allison SD, Molina MC, Anchordoquy TJ. Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim Biophys Acta 2000;1468:127–38
- Kamiya S, Nozawa Y, Miyagishima A, et al. Physical characterization of freeze-dried Griseofulvinlipids nanoparticles. Chem Pharm Bull 2006;54:181–4
- Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 2006;58:1688–713
- De Chasteigner S, Cave G, Fessi H, et al. Freeze-drying of Itraconazole-loaded nanosphere suspensions: a feasibility study. Drug Dev Res 1996;38:116–24
- Schwarz C, Mehnert W. Freeze-drying of drug-free and drug loaded solid lipid nanoparticles. Int J Pharm 1997;157:171–9
- Sonaje K, Lin KJ, Wey SP, et al. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. Biomaterials 2010;31:6849–58
- Sajomsang W. Synthethic methods and application of chitosan containing pyridine methyl moiety and its quaternized derivatives: a review. Carbohydr Polym 2010;80:631–47